While retinoids have been used to treat some cutaneous T-cell lymphomas (CTCLs), their mechanism of action and the role of RARA in CTCL and other mature T-cell lymphomas remain poorly understood. The gene discussed is RARA; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.